CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-22 | 10X Fund, L.P. 10% owner | Sale | −30,000 | $4.94 | $148K | 5,872,207 |
| 2025-09-12 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +8,706 | $1.37 | $12K | 16,320 |
| 2025-09-12 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −8,706 | $6.44 | $56K | 7,614 |
| 2025-09-12 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −8,706 | $1.37 | $12K | 0 |
| 2025-09-12 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +14,000 | $2.39 | $33K | 846,592 |
| 2025-09-12 | LEWIS JOEL President and CEO | Sale 10b5-1 | −14,000 | $6.36 | $89K | 832,592 |
| 2025-09-12 | LEWIS JOEL President and CEO | Option exercise · Stock option (right to buy) 10b5-1 | −14,000 | $2.39 | $33K | 40,250 |
| 2025-07-21 | ELDRED KARY Director | Purchase | +1,000 | $2.93 | $3K | 64,682 |
| 2025-07-17 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.90 | $14K | 49,769 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +31,250 | $0.89 | $28K | 753,666 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +46,875 | $2.39 | $112K | 800,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +25,000 | $4.72 | $118K | 825,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +30,000 | $2.86 | $86K | 855,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +40,000 | $2.11 | $84K | 895,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +70,000 | $2.11 | $148K | 965,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +40,000 | $1.98 | $79K | 1,005,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise | +40,000 | $1.11 | $44K | 1,045,541 |
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −31,250 | 291,875 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −46,875 | 245,000 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −25,000 | 220,000 |
Page 11 of 15 · 291 trades